RCUS in the 13F filings
Arcus Biosciences Inc · CUSIP 03969F109
- Quarter end
- 31 Mar 2024
- the date the book describes
- Filed
- 15 May 2024
- latest of these filings; the earliest 14 May 2024
- Managers listing it
- 5
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q4 2023 and Q1 2024; 3 listed it in both
- Shares listed
- 5,118,006
- combined, among listed positions
- Reported value
- $97m
- combined, at the quarter end
Among the 93 comparable managers: 4 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing RCUS in Q1 2024
5 of 5 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Woodline Partners LP | 2,883,657 | $54m | 0.50% | Added | +1,846,375 | 15 May 2024 (the filing on sec.gov) |
| Point72 Asset Management LP | 1,914,932 | $36m | 0.09% | Added | n.a. | 15 May 2024 (the filing on sec.gov) |
| Hudson Bay Capital Management LP | 165,000 | $3.1m | under 0.1% | Trimmed | -5,000 | 15 May 2024 (the filing on sec.gov) |
| PDT Partners LLC | 97,152 | $1.8m | 0.17% | Added | +82,178 | 15 May 2024 (the filing on sec.gov) |
| Winton Group Ltd | 57,265 | $1.1m | 0.08% | New | new | 14 May 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Woodline Partners LPexisting position · 2,883,657 shares now+1,846,375
- PDT Partners LLCexisting position · 97,152 shares now+82,178
- Winton Group Ltdnew position · 57,265 shares now+57,265
Reductions
- Hudson Bay Capital Management LPexisting position · 165,000 shares now-5,000
New positions and exits
New (1)
- Winton Group Ltd$1.1m
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2018 | 2 | $716k | n.a. | n.a. |
| Q2 2019 | 1 | $133k | n.a. | n.a. |
| Q3 2019 | 1 | $210k | n.a. | n.a. |
| Q1 2020 | 2 | $5.2m | n.a. | n.a. |
| Q2 2020 | 8 | $51m | n.a. | n.a. |
| Q3 2020 | 4 | $12m | n.a. | n.a. |
| Q4 2020 | 2 | $14m | n.a. | n.a. |
| Q1 2021 | 2 | $48m | n.a. | n.a. |
| Q2 2021 | 2 | $48m | n.a. | n.a. |
| Q3 2021 | 1 | $59m | n.a. | n.a. |
| Q4 2021 | 3 | $81m | n.a. | n.a. |
| Q1 2022 | 1 | $8.3m | n.a. | n.a. |
| Q2 2022 | 1 | $3.8m | n.a. | n.a. |
| Q3 2022 | 1 | $1.5m | n.a. | n.a. |
| Q4 2022 | 2 | $26m | n.a. | n.a. |
| Q1 2023 | 5 | $28m | n.a. | n.a. |
| Q2 2023 | 6 | $69m | n.a. | n.a. |
| Q3 2023 | 2 | $23m | n.a. | n.a. |
| Q4 2023 | 4 | $27m | 2 | 1 |
| Q1 2024 | 5 | $97m | 4 | 1 |
| Q2 2024 | 4 | $95m | 2 | 2 |
| Q3 2024 | 5 | $103m | 4 | 1 |
| Q4 2024 | 4 | $85m | 3 | 1 |
| Q1 2025 | 4 | $64m | 3 | 1 |
| Q2 2025 | 3 | $84m | 2 | 1 |
| Q3 2025 | 4 | $117m | 1 | 3 |
| Q4 2025 | 6 | $265m | 12 | 18 |
| Q1 2026 | 5 | $310m | 18 | 9 |
| Q2 2026 | 5 | $346m | 13 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RCUS and LLY →RCUS and JNJ →RCUS and VRTX →Choose a stock to compare with RCUS →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RCUS, latest filings →Back to the 13F Explorer →